FIELD: medicine.
SUBSTANCE: group of inventions relates to biology and medicine. Disclosed is a modified particle for identifying an extracellular vesicle contained in a biological fluid sample having an affinity for at least one marker present in the extracellular vesicle, and consisting of a core of silicon dioxide, gold particles sorbed on the surface of the core, and guiding darpins immobilized on gold particles, and having an affinity for at least one marker present in the extracellular vesicle. Also disclosed are use of said modified particles and a method for identifying extracellular vesicles.
EFFECT: group of inventions provides higher sensitivity and specificity of detecting exosomal markers.
10 cl, 6 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ISOLATION AND ANALYSIS OF EXOSOMES | 2022 |
|
RU2788198C1 |
| VESICLES CONTAINING PTEN INHIBITOR AND THEIR USE | 2019 |
|
RU2800729C2 |
| EXO-SOMATIC BIOMARKERS | 2015 |
|
RU2712223C2 |
| METHOD OF DETERMINING COMPOSITION OF INDIVIDUAL EXTRACELLULAR VESICLES IN HUMAN BLOOD | 2014 |
|
RU2583940C1 |
| METHOD FOR PLASMA EXOSOME RELEASE | 2020 |
|
RU2741638C1 |
| USE OF POROUS FIBERS FOR OBTAINING BLOOD OR BLOOD DERIVATIVE DEPUTY IN BLOOD CELLS AND PLATELETS FROM EXTRACELLULAR VESICLES | 2019 |
|
RU2796378C2 |
| BIOLOGICAL MICROCHIP FOR DETECTION OF TUMOR EXOSOMES IN SERUM OF HUMAN FOR DIAGNOSING COLORECTAL CANCER | 2016 |
|
RU2682721C2 |
| METHOD FOR TARGETED IMPACT ON EXOSOMES | 2018 |
|
RU2781640C2 |
| METHOD FOR DIAGNOSING HODGKIN LYMPHOMA | 2021 |
|
RU2782326C1 |
| NUCLEOTIDE SEQUENCE EXPRESSING ANCHOR PROTEIN OF EXOSOMES FOR USE AS VACCINE | 2017 |
|
RU2761642C2 |
